Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | +5.49% |
|
-1.10% | +62.05% |
05-30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
05-07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.05% | 259M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.88% | 26.64B | |
-21.81% | 19.91B | |
-17.03% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- ADC Therapeutics Q1 Loss Narrows, Names New CEO; Shares Sink